Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion type Assertion NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_head.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion description "[ZnT8 was therefore proposed as a therapeutic target for diabetes, and recent genome-wide association studies identified polymorphisms in the ZNT8 gene conferring increased type 2 diabetes risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_provenance.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion evidence source_evidence_literature NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_provenance.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion SIO_000772 19095428 NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_provenance.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion wasDerivedFrom befree-20140225 NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_provenance.
- NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_assertion wasGeneratedBy ECO_0000203 NP498811.RAwpxU5Zvh5DW_ZN-v-gqndlBw5YgWQFTM-mD9fLnqnyI130_provenance.